Filter Results
:
(127)
Show Results For
-
All HBS Web
(127)
- News (44)
- Research (61)
- Multimedia (1)
- Faculty Publications (35)
Show Results For
-
All HBS Web
(127)
- News (44)
- Research (61)
- Multimedia (1)
- Faculty Publications (35)
- 27 Sep 2019
- Blog Post
HBS Alumni and Students Take On the Climate Crisis
prairies west of Houston to mitigate the environmental impact of development through investment in conserving water-absorbing grasslands. THE BLUE-GREEN REVOLUTION Synthetic Genomics Inc., a private biotech company co-founded by Juan...
View Details
- 01 Jan 2006
- News
Philip L. Yeo, MBA 1976
draft of the Human Genome Project, we launched the Biomedical Sciences Initiative here." As Singapore set out on this journey, Yeo made sure that plenty of funding was available to nurture and sustain the new ventures. From 2000 to 2005,...
View Details
- 01 Jun 2017
- News
Drawing on the Crowd for Innovative Problem-Solving
Institute of MIT and Harvard to further genomic research, developing a contest that aimed to improve the benchmark algorithm set by Broad scientists, which it did, 14 times faster. Lakhani explains that when structuring an experiment, he...
View Details
- 01 Mar 2018
- News
Excellence At The Intersection Of Disciplines
boundaries of their particular schools to address society’s most exciting opportunities and challenging issues. In the Harvard Innovation Labs, for example, members of the Harvard community are developing and carrying forward ideas for ventures in areas ranging from...
View Details
- 01 Dec 2003
- News
The Next Big Thing
center recently established in Cambridge to advance genetics-based medicine. Summers, Vest, and Lander all remarked on the promise the genomic revolution holds for society, the need to facilitate its emergence and commercialize its...
View Details
- 02 Apr 2013
- First Look
First Look: April 2
Publications 2006 Nature Reviews Beyond Magic Bullets: True Innovation in Health Care By: Narayan, Vaibhav A., Marco Mohwinckel, Gary Pisano, Michael Yang, and Husseini Manji Abstract—The molecular medicine revolution-based on advances in fields such as View Details
Keywords:
Sean Silverthorne
- 01 Sep 2008
- News
Mara Aspinall
of personalized medicine into clinical practice. Why does it seem that science is often so far ahead of practice in the medical field? Science has moved especially quickly in the last five years with the completion of the Human Genome...
View Details
- 01 Jun 2000
- News
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. When trying to secure backing for a high-risk start-up, whom you know can be just as...
View Details
Keywords:
Judith A. Ross
- 01 Aug 2002
- News
For Alumni Only: Breakthrough Insights Program Debuts
case on the biotechnology firm Biogen, where a seemingly innocuous decision to license databases of new proteins discovered through genomic research wound up completely transforming the company's product-development process. As Vietor led...
View Details
Keywords:
Laura Singleton
- 19 Aug 2002
- Research & Ideas
Here Comes Internet2—Time to Shed Dot Vertigo
The same DVD would take approximately twenty-five hours to download via a standard DSL/cable line (and 170 hours—or more than seven days—via a 56K modem). Genomics and pharmaceuticals are other research arenas that should benefit from the...
View Details
Keywords:
by Martha Lagace
- 07 Nov 2017
- First Look
New Research and Ideas: November 7, 2017
Intermountain’s oncology team in 2013 and spearheaded the creation of Intermountain Precision Genomics (IPG). By 2016, IPG had a cutting-edge genomic sequencing laboratory that provided sequencing services...
View Details
Keywords:
Carmen Nobel
- 06 Dec 2017
- Blog Post
The 23rd Annual Harvard Business School Tech Conference
highlighted how the trend of decreasing the cost of sequencing a human genome will be even more disruptive than Moore’s law. Right after Deep, Eric Paley spoke about his investment philosophy and how he thinks prorata (a right to invest...
View Details
Keywords:
Technology
- 03 Mar 2015
- First Look
First Look: March 3
Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/715019-PDF-ENG Harvard Business School Case 814-050 GenapSys: Business Models for the Genome GenapSys, a California-based startup, was soon to release a new DNA sequencer that...
View Details
Keywords:
Sean Silverthorne
- Profile
Terrance McGuire
such success stories as Akamai Technologies, which enabled the rapid movement of data over the Internet, and deCODE Genetics, a global leader in analyzing the human genome based in Iceland. Early on, Polaris decided to invest in the...
View Details
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
dialysis device, a femtech device using genomics to enable women’s care, a biosensing wearable to prevent dehydration, and an oxygen sensor for personalized oncology care. They have collectively raised more than $485M in funding and an...
View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
question—it’s clear.” Simply put, inefficiencies in the development of precision medicine can best be addressed by a business-analysis approach. With the mapping of the human genome completed 15 years ago, the sci-fi concept of using a...
View Details
- 15 Feb 2000
- Research & Ideas
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. But when vying against others in industries where high uncertainty, long development...
View Details
Keywords:
by Judith A. Ross
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
says, "will kill us financially and medically it will ruin our economy, deny us the health care services we need, and undermine the important genomic research that can fundamentally improve the practice of medicine and control its...
View Details
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
when VC firm Mohr Davidow made an investment in Navigenics, a direct competitor to personal genomics company 23andMe, a startup it had invested in previously. A year later, a similar case occurred when Andreesen Horowitz cut its...
View Details
- 05 Aug 2002
- Research & Ideas
Are Consumers the Cure for Broken Health Insurance?
patient-protection legislation promising to set off a round of expensive lawsuits, and costly genomic technologies on the horizon, the price of insurance is almost certain to continue its upward spiral in the years ahead. And what do...
View Details
Keywords:
by Regina E. Herzlinger